Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 609-624, October 2009

Developing outcome measures for paediatric rheumatic diseases

  • Hermine I. Brunner, MD MSc

      Affiliations

    • Cincinnati Children's Hospital Medical Center, University of Cincinnati, William Rowe Division of Rheumatology, E 4010, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 513 636 7467; Fax: +1 513 636 5990.
  • ,
  • Angelo Ravelli, MD

      Affiliations

    • Dipartimento di Scienze Pediatriche G. De Toni, Università degli Studi di Genova and Istituto di Ricovero e Cura a Carattere Scientifico G. Gaslini, Genova, Italy

This review provides a theoretical background and approach for developing outcome measures that are often used to assess the state and course of paediatric rheumatic diseases. It describes the important steps in scale development such as item generation and reduction, the assessment of scale reliability and various forms of validation. The second part of this review described the newly developed outcome measures as well as their state of validation. These outcome measures include therapeutic response measures, composite disease activity scores for juvenile idiopathic arthritis (JIA), global disease activity tools for juvenile systemic lupus erythematosus and juvenile dermatomyositis, disease status measures in JIA, measures of physical function, measures of health-related quality of life, clinical measures of damage and radiographic scoring systems in JIA.

Keywords: response criteria, flare, remission, consensus methodology, juvenile idiopathic arthritis, juvenile systemic lupus erythematosus, juvenile dermatomyositis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Brunner is supported by a grant funded NIAMS P60 AR047784; Methodology Core.

PII: S1521-6942(09)00073-4

doi:10.1016/j.berh.2009.07.001

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 5 , Pages 609-624, October 2009